These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32888903)

  • 1. Efficacy and Safety of Topical Cysteamine in Corneal Cystinosis: A Systematic Review and Meta-Analysis.
    Kaur S; Sarma P; Kaur H; Prajapat M; Shekhar N; Bhattacharyya J; Kaur H; Kumar S; Medhi B; Ram J; Das D; Avti P; Prakash A; Singh R; Bhattacharyya A
    Am J Ophthalmol; 2021 Mar; 223():275-285. PubMed ID: 32888903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.
    Liang H; Labbé A; Le Mouhaër J; Plisson C; Baudouin C
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2275-2283. PubMed ID: 28426870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.
    Labbé A; Baudouin C; Deschênes G; Loirat C; Charbit M; Guest G; Niaudet P
    Mol Genet Metab; 2014 Mar; 111(3):314-320. PubMed ID: 24440466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topical cysteamine in nephropathic cystinosis.
    Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ozdemir HB; Özmen MC; Aktas Z; Hasanreisoglu M
    Indian J Ophthalmol; 2019 Jan; 67(1):153-155. PubMed ID: 30574930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular treatment of cystinosis with eye drop containing cysteamine].
    Csorba A; Maka E; Szabó A; Kelen K; Reusz G; Nagy ZZ
    Orv Hetil; 2022 May; 163(21):846-852. PubMed ID: 35598215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of topical cysteamine formulated from the oral preparation in a child with keratopathy secondary to cystinosis.
    Khan AO; Latimer B
    Am J Ophthalmol; 2004 Oct; 138(4):674-5. PubMed ID: 15488810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of cystinosis patients treated with 0.55% cysteamine hydrochloride.
    Liang H; Labbé A; Baudouin C; Plisson C; Giordano V
    Br J Ophthalmol; 2021 May; 105(5):608-613. PubMed ID: 32593979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.
    Tsilou ET; Thompson D; Lindblad AS; Reed GF; Rubin B; Gahl W; Thoene J; Del Monte M; Schneider JA; Granet DB; Kaiser-Kupfer MI
    Br J Ophthalmol; 2003 Jan; 87(1):28-31. PubMed ID: 12488257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis.
    Bradbury JA; Danjoux JP; Voller J; Spencer M; Brocklebank T
    Eye (Lond); 1991; 5 ( Pt 6)():755-60. PubMed ID: 1800180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of treatment with cysteamine eyedrops for cystinosis with confocal microscopy.
    Tavares R; Coelho D; Macário MC; Torres A; Quadrado MJ; Murta J
    Cornea; 2009 Sep; 28(8):938-40. PubMed ID: 19654516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
    Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
    Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.
    Simpson JL; Nien CJ; Flynn KJ; Jester JV
    Mol Vis; 2011; 17():2649-54. PubMed ID: 22065917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis.
    Kaiser-Kupfer MI; Fujikawa L; Kuwabara T; Jain S; Gahl WA
    N Engl J Med; 1987 Mar; 316(13):775-9. PubMed ID: 3821824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops
    Sergio P; Giancarlo I; Matteo F; Maria SC; Gianni P; Parrilla R; Valente P; Luca B
    Eur J Ophthalmol; 2022 Nov; 32(6):3358-3362. PubMed ID: 35125035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephropathic cystinosis in children: An overlooked disease.
    Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term cysteamine treatment in patients with cystinosis.
    Ariceta G; Giordano V; Santos F
    Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis.
    Marcano DC; Shin CS; Lee B; Isenhart LC; Liu X; Li F; Jester JV; Pflugfelder SC; Simpson J; Acharya G
    Mol Pharm; 2016 Oct; 13(10):3468-3477. PubMed ID: 27571217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.